Regional and systemic hemodynamic disturbances in cirrhosis

Clinics in Liver Disease

Volumn 5, Issue 3, 2001, Pages 617-627

  Menon, K V Narayanan ^b   Kamath, Patrick S ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLATERAL CIRCULATION; HEPATOPULMONARY SYNDROME; KIDNEY BLOOD FLOW; LIVER CIRRHOSIS; LUNG HEMODYNAMICS; PORTOSYSTEMIC ANASTOMOSIS; PULMONARY HYPERTENSION; REVIEW; SPLANCHNIC BLOOD FLOW;

EID: 0034848631     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70184-7     Document Type: Article

References (62)

1. Vasodilatation and sodium retention in prehepatic portal hypertension
2. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases
3. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: Preliminary report of a prospective study
4. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
5. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease
6. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients
7. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients
8. Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: Effect of liver transplantation
9. Hepatopulmonary syndrome in noncirrhotic portal hypertension
10. Coexistent pulmonary and portal hypertension: Morphologic and clinical features
11. Hepatorenal syndrome: Emerging perspectives of pathophysiology and therapy
12. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome
13. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
14. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
15. Pathogenesis of ascites in cirrhosis
16. Increased cerebrovascular resistance in cirrhotic patients with ascites
17. Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of nitric oxide
18. Pulmonary vascular disorders in portal hypertension
19. Hepatic lipocytes: A major target for endothelin-1
20. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt
21. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension
22. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy
23. Hepatopulmonary syndromes
24. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue
25. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
26. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation
27. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: Case reports and literature review
28. Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study
29. Hepatorenal reflex regulating kidney function
30. The hepatopulmonary syndrome
31. Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis
32. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats
33. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy
34. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats
35. Tumor necrosis factor alpha: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats
36. Transjugular intrahepatic portosystemic shunt: Short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis
37. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis
38. Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome
39. The hepatopulmonary syndrome: Radiologic findings in 10 patients
40. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
41. Regional cerebral blood flow and cognitive function in patients with chronic liver disease
42. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat
43. Collagenisation of the Disse space in alcoholic liver disease
44. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
45. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy
46. Severe pulmonary hypertension in liver transplant candidates
47. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing
48. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
49. Reduction of cerebral blood flow in subclinical hepatic encephalopathy and its correlation with plasma-free tryptophan
50. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension: Preliminary results
51. Urinary endothelin-like immunoreactivity in patients with cirrhosis
52. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat
53. Localization of increased hepatic vascular resistance in liver cirrhosis
54. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model
55. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease
56. Carbon monoxide: An endogenous modulator of sinusoidal tone in the perfused rat liver
57. Increased angiogenesis in portal hypertensive rats: Role of nitric oxide
58. Cerebral blood flow and plasma free tryptophan in cirrhotics with and without hepatic encephalopathy
59. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
60. Hyperdynamic circulation in portal-hypertensive rat model: A primary factor for maintenance of chronic portal hypertension
61. Increased blood flow through the portal system in cirrhotic rats
62. Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites